(ALKS:Consolidated Issue Listed on NASDAQ Global Select )
David Westbrook Anstice
Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee,Alkermes plc
|Age||Total Calculated Compensation||This person is connected to 134 board members in 6 different organizations across 5 different industries.|
See Board Relationships
Mr. David Westbrook Anstice served as the President of MSD K.K. Mr. Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co. Inc., from September 2006 to September 2008. He served as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent ...
Connaught HousePhone: 353 1 772 8000
Dublin, Co. Dublin 4
Board Members Memberships*
Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
Bachelor's Degree 1970
University Of Sydney
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|David M. Stack||Chairman, Chief Executive Officer and President|
Pacira Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|George Frederick Wilkinson||Chief Executive Officer, President and Director|
Impax Laboratories Inc.
|Bruce C. Cozadd||Co-Founder, Executive Chairman and Chief Executive Officer|
Jazz Pharmaceuticals Public Limited Company
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|$1.2M||Compensation as of Fiscal Year 2014.|